文献速递儿童心血管与肾脏儿童消化与营养

铁缺乏与儿科心力衰竭不良结局相关

Iron Deficiency Is Associated with Adverse Outcomes in Pediatric Heart Failure.
PubMed 文献 · J Pediatr · 2019-10-11

该单中心回顾性队列研究纳入2012年7月至2017年6月年龄1-21岁、有心力衰竭且具备血清铁检查的107例患者(双心室收缩性心衰77例,单心室先天性心脏病合并收缩性心衰30例),铁缺乏定义为以下≥2项:血清铁<50 μg/dL、血清铁蛋白<20 ng/mL、转铁蛋白>300 ng/mL或转铁蛋白饱和度<15%。56%的患者存在铁缺乏,在双心室组铁缺乏与3个月和6个月复合不良事件(心室辅助装置植入、心脏移植或死亡)相关,在单心室组与6个月复合不良事件相关。

要点

  • 56%的儿科心衰患者存在铁缺乏。
  • 双心室组铁缺乏与3个月和6个月复合不良事件相关。
  • 单心室组铁缺乏与6个月复合不良事件相关。

核心结论

  • 铁缺乏在儿科心衰患者中普遍存在,且与心室辅助装置植入、心脏移植或死亡风险增加相关。

研究设计与样本

  • 单中心回顾性队列研究,纳入2012年7月至2017年6月年龄1-21岁、有心力衰竭且具备血清铁检查的患者107例(双心室收缩性心衰77例,单心室先天性心脏病合并收缩性心衰30例)。

主要发现

  • 56%的患者存在铁缺乏。
  • 人口学特征、心衰病因及心衰症状慢性程度与铁缺乏无关。

关键数值与推荐

  • 铁缺乏定义为以下≥2项:血清铁<50 μg/dL、血清铁蛋白<20 ng/mL、转铁蛋白>300 ng/mL或转铁蛋白饱和度<15%。

临床怎么用

  • 对儿科心衰患者应评估铁缺乏状态,铁缺乏可能提示更高的心室辅助装置植入、心脏移植或死亡风险。

局限性

  • 本研究为单中心回顾性队列研究,仅纳入具备血清铁检查的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the prevalence of iron deficiency and its association with outcomes in children with heart failure. STUDY DESIGN: A single-center retrospective cohort study of patients with heart failure aged 1-21 years from July 2012 to June 2017 with available serum iron studies was performed. Subjects were analyzed in 2 groups: biventricular systolic heart failure (BiV) and single-ventricle congenital heart disease with systolic heart failure (SV). Iron deficiency was defined as ≥2 of the following: serum iron <50 μg/dL, serum ferritin <20 ng/mL, transferrin >300 ng/mL, or transferrin saturation <15%. The primary outcome was a composite adverse event (CAE) of ventricular assist device implantation, heart transplantation, or death, at 3 and 6 months from time of iron studies. RESULTS: Of the 107 subjects (77 BiV, 30 SV) included in the study, 56% were iron deficient. Demographics, etiology of heart failure, and chronicity of heart failure symptoms were not associated with iron deficiency. On multivariable analysis, in group BiV, iron deficiency was associated with CAE at 3 months (79% iron deficiency in CAE group vs 37% iron deficiency in non-CAE, P = .001, OR 7, 95% CI 2-21) and 6 months (76% iron deficiency in CAE vs 35% iron deficiency in non-CAE, P = .002, OR 7, 95% CI 2-24). In group SV, iron deficiency was associated with CAE at 6 months (79% iron deficiency in CAE vs 29% iron deficiency in non-CAE, P = .014, OR 8, 95% CI 2-32). CONCLUSIONS: Iron deficiency was present in 56% of the pediatric patients with heart failure who were evaluated with iron studies. Iron deficiency was associated with greater risk of ventricular assist device implantation, heart transplantation, or death.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Puri K, Price JF, Spinner JA, et al. Iron Deficiency Is Associated with Adverse Outcomes in Pediatric Heart Failure. J Pediatr. 2019. PMID: 31610927. doi:10.1016/j.jpeds.2019.08.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。